AMH and polycystic ovary syndrome: The implementation of the Elecsys AMH Plus immunoassay therefore has the potential to result in further economic benefits with regard to this population, where an earlier diagnosis of PCOS could lead to earlier fertility treatment, assessment of comorbidities, and support with lifestyle interventions.